Business Wire

Protegrity Data Protection Platform and Cloud Protect for Snowflake Now Available in the Microsoft Azure Marketplace

18.11.2021 17:00:00 EET | Business Wire | Press release

Share

Protegrity, a global leader in data security, today announced the availability of the Protegrity Data Protection Platform and Cloud Protect for Snowflake in the Microsoft Azure Marketplace, an online store providing applications and services for use on Microsoft Azure. Protegrity customers can now take advantage of the scalability, high availability, and security of Azure, with streamlined deployment and management.

Additionally, Protegrity has achieved Microsoft’s stringent Co-Sell Ready designation, unlocking the development of joint solutions, sales, and support through the Microsoft One Commercial Partner Program. Protegrity has also joined the Microsoft FastTrack certification program.

“Due to heightened sensitivity over data and privacy, many organizations have been slower to adopt cloud solutions,” said Jay Chitnis, vice president, global alliances and partners at Protegrity. “However, we’re now seeing a tipping point with businesses. Many of them want to make the most of the cloud to support AI and machine learning initiatives, so they can gain valuable insights from data, but they also recognize they have to safeguard the privacy of their customers, partners, and employees. That’s why it’s critical for organizations to secure data in any form and wherever it is—in the cloud or on premises—so it can be accessed across the enterprise by front-line employees, analytics teams, and anyone who needs data intelligence to make business decisions. Our collaboration with Microsoft ensures our mutual customers’ data is not at risk as it moves to the cloud, allowing organizations to accelerate cloud adoption.”

Jake Zborowski, general manager, Microsoft Azure Platform at Microsoft Corp., said, “We’re pleased to welcome Protegrity's solutions to the Microsoft Azure Marketplace, which gives our partners great exposure to cloud customers around the globe. Azure Marketplace offers world-class quality experiences from global trusted partners with solutions tested to work seamlessly with Azure.”

The Azure Marketplace is an online market for buying and selling cloud solutions certified to run on Azure. The Azure Marketplace helps connect companies seeking innovative, cloud-based solutions with partners who have developed solutions that are ready to use.

Seamless Data Protection to Support Advanced Analytics, AI, and Machine Learning on Microsoft Azure

As part of the Co-Sell Ready achievement, Protegrity met Microsoft’s strict architecture and security requirements. Protegrity will also continue to work with Microsoft account teams and partners to seamlessly deliver modern data protection and data privacy solutions to joint customers while supporting advanced analytics, AI, and machine learning, and Microsoft Azure cloud initiatives. Additionally, as part of the FastTrack program, Protegrity’s commitment to Microsoft Azure-based solutions will provide native security and performance for mutual customers.

Protegrity’s enterprise-class Data Protection Platform integration with Microsoft Azure enables customers to apply data-protection policies across different environments, entities, and jurisdictions. Additionally, customers are able to:

  • Secure data moving to the cloud to reduce operational risk;
  • Govern data in the cloud leveraging enterprise-wide information security policies; and
  • Unlock and secure data analytics capabilities in the cloud.

Built for hybrid-cloud and multi-cloud, the Protegrity Data Protection Platform allows companies to seamlessly deploy and update data security policies across geographies, departments, and digital transformation programs. Businesses can quickly and safely turn sensitive data into intelligence-driven insights to deliver better customer experiences, monetize data responsibly, and support AI and machine learning initiatives.

Protegrity Data Protection Platform and Cloud Protect for Snowflake on Microsoft Azure Safeguard Sensitive Data for Privacy Compliance

Now available on the Microsoft Azure Marketplace, the Protegrity Data Protection Platform provides customers with fine-grained data protection capabilities for sensitive data and compliance. Protegrity accelerates analytics; minimizes risk in enterprise cloud adoption and migration; and meets storage, big data, and workload requirements. With its format-preserving vaultless tokenization capabilities and other forms of encryption, Protegrity safeguards data throughout every step of the data lifecycle.

Protegrity also announced the availability of Cloud Protect for Snowflake, which bundles two serverless components, the Snowflake Protector and Cloud API, to protect customers’ data and accelerate cloud migration and adoption of Snowflake.

  • Snowflake Protector: The Snowflake Protector is a purpose-built protector that integrates seamlessly with Snowflake SQL to easily protect and unprotect sensitive data. Elastically scalable and benchmarked for high performance, the Protegrity Snowflake Protector enables organizations to support even the largest workloads.
  • Cloud API: The Cloud API provides a general tokenization REST endpoint for use within ETL workflows. It can be used to protect data prior to ingestion into Snowflake, ensuring that data is always protected at rest.

With its support for Microsoft Azure, Protegrity continues to deliver on its commitment to expand cloud-inclusivity, enabling customers to maintain enterprise-wide data protection wherever sensitive data resides. Support for Microsoft points to one of many integrations Protegrity has with cloud providers as part of the new Protegrity Partner Network—a collaboration with leading technology companies that enables organizations to protect data in the cloud, regardless of vendor. With the freedom to safeguard data in any cloud system or application, organizations can unlock the potential of secure data no matter where it is and create more opportunities for innovation and digital transformation and improve customer experiences.

Learn more

Website: protegrity.com
Twitter: @Protegrity
LinkedIn: linkedin.com/company/protegrity

About Protegrity

Protegrity, a global leader in data security, protects sensitive data everywhere and future-proofs businesses as data-privacy regulations evolve. Maintaining privacy today across distributed data has become impossibly complicated. With Protegrity, enterprises can secure data wherever it resides, control how it’s protected, and have confidence that data is safe, even if a breach occurs. The Protegrity Data Protection Platform is a modern alternative to traditionally complex data-protection methods that leave gaps in security. Whether encrypting, tokenizing, or applying privacy models, Protegrity protects data at the speed of business. Deep integrations with Snowflake, Amazon Redshift, Teradata, Oracle, Microsoft SQL Server, Cloudera, Databricks, and many other enterprise applications ensure that data remains fully protected in hybrid-cloud, multi-cloud, and on-premises environments. The platform’s fine-grained data protection anonymizes personally identifiable information (PII) that’s used in AI and machine learning models, providing faster access to critical analytics data and dramatically shortening the time to business insights. Protegrity protects the sensitive data of more than two billion individuals across global enterprises, including four of the world’s 15 largest banks, four out of 10 of the top health insurance providers, and three of the world’s leading multinational companies. With more than two decades of industry-leading innovation, Protegrity allows businesses to finally tap into the value of their data and accelerate digital transformation timelines – without jeopardizing individuals’ fundamental right to privacy.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Andrew Smith
Bhava Communications for Protegrity
protegrity@bhavacom.com
+1 (310) 941-7251

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye